Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹2,920 Cr
Revenue (TTM)
₹500 Cr
Net Profit (TTM)
₹13 Cr
ROE
2.7 %
ROCE
5.2 %
P/E Ratio
221
P/B Ratio
4.2
Industry P/E
29.19
EV/EBITDA
66
Div. Yield
0.1 %
Debt to Equity
0.1
Book Value
₹53.5
EPS
₹1
Face value
1
Shares outstanding
129,669,080
CFO
₹101.59 Cr
EBITDA
₹357.42 Cr
Net Profit
₹157.57 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bhagiradha Chem
| 4.4 | 15.3 | 0.7 | -17.9 | 21.7 | -- | -- |
|
BSE Commodities
| 0.5 | -0.2 | -2.6 | 20.1 | 16.7 | 12.1 | 16.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Bhagiradha Chem
| -27.0 | 97.8 | 18.3 | 50.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bhagiradha Chem
|
229.4 | 2,920.2 | 500.5 | 13.2 | 5.5 | 1.9 | 221 | 4.2 |
| 4,811.1 | 21,445.5 | 5,620.6 | 670.4 | 13.4 | 22.4 | 32 | 6.7 | |
| 1,435.2 | 2,406.7 | 1,240.4 | 132.3 | 13.1 | 12.2 | 18.1 | 1.9 | |
| 1,015.1 | 4,584.5 | 1,978.5 | 265.0 | 16.3 | 18 | 17.3 | 2.9 | |
| 146.2 | 1,669.9 | 998.2 | 111.0 | 14.3 | 12 | 15.1 | 1.7 | |
| 644.0 | 1,867.5 | 2,072.7 | 140.8 | 9.5 | 12.4 | 13.2 | 1.5 | |
| 166.7 | 3,892.0 | 1,424.9 | -44.7 | -1.1 | -13.7 | -- | 5.7 | |
| 258.7 | 5,065.9 | 2,871.0 | 167.0 | 7.8 | 11.7 | 30.3 | 2.5 | |
| 1,052.4 | 9,484.0 | 5,031.2 | 565.9 | 9.9 | 21.9 | 16.8 | 3.4 | |
| 410.4 | 20,397.6 | 3,234.0 | 531.4 | 18.3 | 17.8 | 38.4 | 6.2 |
2 min read•By Rajan Gulati
Bhagiradha Chemicals & Industries Limited manufactures and sells crop protection chemicals in India, Asia, Australia, and Europe. The company offers insecticides, such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran,... thiamethoxam, imidacloprid, pymetrozine, and chlorantraniliprole; fungicides, including azoxystrobin and trifloxystrobin; herbicides comprising triclopyr, cloquintocet-mexyl, clodinafop-propargyl, sulfosulfuron, and pinoxaden; and specialty intermediates, such as 2,6-dichloroaniline and 2-ethylsulfonylimidazo pyridine-3-sulfonamide. Bhagiradha Chemicals & Industries Limited was incorporated in 1993 and is headquartered in Hyderabad, India. Read more
Incorporated
1993
Chairman
Kishor Shah
Managing Director
S Chandra Sekhar
Headquarters
Hyderabad, Telangana
Website
Looking for more details about Bhagiradha Chemicals & Industries Ltd.’s IPO? Explore our IPO Details page.
The share price of Bhagiradha Chemicals & Industries Ltd is ₹229.43 (NSE) and ₹228.25 (BSE) as of 08-Apr-2026 IST. Bhagiradha Chemicals & Industries Ltd has given a return of 21.71% in the last 3 years.
The P/E ratio of Bhagiradha Chemicals & Industries Ltd is 220.97 times as on 08-Apr-2026, a 657 premium to its peers’ median range of 29.19 times.
The P/B ratio of Bhagiradha Chemicals & Industries Ltd is 4.21 times as on 08-Apr-2026, a 47 premium to its peers’ median range of 2.87 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
260.13
|
5.28
|
|
2024
|
9.20
|
5.10
|
|
2023
|
2.76
|
3.98
|
|
2022
|
2.07
|
4.44
|
|
2021
|
15.77
|
2.70
|
The 52-week high and low of Bhagiradha Chemicals & Industries Ltd are Rs 331.00 and Rs 170.60 as of 08-Apr-2026.
Bhagiradha Chemicals & Industries Ltd has a market capitalisation of ₹ 2,920 Cr as on 08-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Bhagiradha Chemicals & Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.